Company Overview of Envisia Therapeutics Inc.
Envisia Therapeutics Inc. is engaged in the discovery and development of ocular therapeutics for the critical needs in ophthalmology. The company offers ENV515, a prostaglandin analogue that uses a biodegradable PRINT particle formulation to provide sustained intraocular pressure reduction over months. It also provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic, chemical, or other barriers that limit existing ocular therapies; therapeutics based on biocompatible polymers for the delivery of medicines with extended-release kinetics; and topical therapies for treating ocular diseases. The company was founded in 2013 and is based in Morrisville, North ...
419 Davis Drive
Morrisville, NC 27560
Founded in 2013
Key Executives for Envisia Therapeutics Inc.
Chief Executive Officer and Director
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.
Envisia Therapeutics Inc. Key Developments
Envisia Therapeutics Announces Appointments to Board of Directors
Jul 30 14
Envisia Therapeutics announced that it has made two appointments to the company's board of directors. Effective immediately, Adrienne Graves, Ph.D. and Gary Phillips, M.D. will join the board as non-executive members. Dr. Graves was formerly President and Chief Executive Officer of Santen USA, a division of Santen Co. Ltd. Dr. Gary Phillips has more than 20 years' experience in strategy, business development and licensing, commercial operations, business analytics, and clinical medicine in the pharmaceutical and healthcare industries. He is currently the Senior Vice President and Chief Strategy Officer at Mallinckrodt Pharmaceuticals.
Envisia Therapeutics Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 01:25 PM
Feb 4 14
Envisia Therapeutics Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 01:25 PM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Neal F. Fowler, Chief Executive Officer and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 8, 2013
Most Searched Private Companies
Sponsored Financial Commentaries